These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9046978)
1. Naltrexone in the treatment of alcoholism. Weinrieb RM; O'Brien CP Annu Rev Med; 1997; 48():477-87. PubMed ID: 9046978 [TBL] [Abstract][Full Text] [Related]
2. Barriers to the use of medications to treat alcoholism. Mark TL; Kranzler HR; Poole VH; Hagen CA; McLeod C; Crosse S Am J Addict; 2003; 12(4):281-94. PubMed ID: 14504021 [TBL] [Abstract][Full Text] [Related]
3. Advances in the use of naltrexone: an integration of preclinical and clinical findings. O'Malley SS; Froehlich JC Recent Dev Alcohol; 2003; 16():217-45. PubMed ID: 12638640 [TBL] [Abstract][Full Text] [Related]
4. Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone. Kiefer F; Jiménez-Arriero MA; Klein O; Diehl A; Rubio G Addict Biol; 2008 Mar; 13(1):124-9. PubMed ID: 17573782 [TBL] [Abstract][Full Text] [Related]
5. Medical management of alcohol dependence: clinical use and limitations of naltrexone treatment. Volpicelli JR; Volpicelli LA; O'Brien CP Alcohol Alcohol; 1995 Nov; 30(6):789-98. PubMed ID: 8679021 [TBL] [Abstract][Full Text] [Related]
6. Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients. Pettinati HM; Volpicelli JR; Pierce JD; O'Brien CP J Addict Dis; 2000; 19(1):71-83. PubMed ID: 10772604 [TBL] [Abstract][Full Text] [Related]
7. Opioid antagonists in the treatment of alcohol dependence: clinical efficacy and prevention of relapse. O'Malley SS Alcohol Alcohol; 1996 Mar; 31 Suppl 1():77-81. PubMed ID: 8737005 [TBL] [Abstract][Full Text] [Related]
8. A morphine/naltrexone combination (Embeda) for pain. Med Lett Drugs Ther; 2010 Mar; 52(1334):22-3. PubMed ID: 20336033 [No Abstract] [Full Text] [Related]
9. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818 [TBL] [Abstract][Full Text] [Related]
10. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study. Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401 [TBL] [Abstract][Full Text] [Related]
17. Current strategies for the treatment of alcohol dependence in the United States. O'Malley SS Drug Alcohol Depend; 1995 Sep; 39 Suppl 1():S3-7. PubMed ID: 8565795 [TBL] [Abstract][Full Text] [Related]
18. Naltrexone for drinking problems: useful further evidence on efficacy. Chick J Addiction; 2001 Dec; 96(12):1856. PubMed ID: 11791531 [No Abstract] [Full Text] [Related]
19. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. Grant JE; Kim SW; Odlaug BL Biol Psychiatry; 2009 Apr; 65(7):600-6. PubMed ID: 19217077 [TBL] [Abstract][Full Text] [Related]
20. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials. Snyder JL; Bowers TG Am J Drug Alcohol Abuse; 2008; 34(4):449-61. PubMed ID: 18584575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]